- Home
- Equipment
- usa georgia
- diagnostic imaging
Refine by
Diagnostic Imaging Equipment Supplied In Georgia (USA)
5 equipment items found
Manufactured by:OXOS Medical based inAtlanta, GEORGIA (US) (USA)
The MC2 Go is a compact and portable X-ray device designed to meet the mobile diagnostic imaging needs across various healthcare settings. This robust solution features a completely wireless design, offering unparalleled flexibility for patient care on the move, whether it's in sports facilities or during medical transport. ...
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
The suprachoroidal space is a potential space that traverses the circumference of the eye’s posterior region and lies internal to the sclera and external to the choroid. The innermost layer of the choroid, known as Bruch’s membrane, is compact. The outermost border is more a zone of transition, consisting of several lamellae with variable thickness. Because of its proximity to the ...
Manufactured by:OXOS Medical based inAtlanta, GEORGIA (US) (USA)
The MC2 LE is a specialized portable X-ray system crafted for efficient diagnostic imaging of lower extremities. It is designed to cater to the unique needs of lower extremity specialists by providing weight-bearing imaging capabilities, which are critical for accurate assessment and treatment planning. This device supports ...
Manufactured by:Koning Corporation based inNorcross, GEORGIA (US) (USA)
Koning’s 3D KBCT produces high-contrast Real 3D images of the breast with exceptional spatial resolution, no painful compression, in a rapid 10-second exposure, at radiation levels in the range of diagnostic mammograms ...
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
CLS-AX (axitinib injectable suspension) is a proprietary suspension of axitinib for suprachoroidal use. Axitinib is a tyrosine kinase inhibitor (TKI) currently approved to treat renal cell cancer that achieves pan-VEGF blockade, directly inhibiting VEGF receptors-1, -2, and -3 with high potency and specificity. We believe this broad VEGF blockade may have efficacy advantages over existing retinal ...